NEUPATH HEALTH INC (NPTH.CA) Fundamental Analysis & Valuation

TSX-V:NPTH • CA64133P1009

0.45 CAD
-0.01 (-2.17%)
Last: Mar 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This NPTH.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NPTH. NPTH was compared to 13 industry peers in the Health Care Providers & Services industry. While NPTH seems to be doing ok healthwise, there are quite some concerns on its profitability. NPTH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. NPTH.CA Profitability Analysis

1.1 Basic Checks

  • In the past year NPTH has reported negative net income.
  • In the past year NPTH had a positive cash flow from operations.
  • NPTH had negative earnings in each of the past 5 years.
  • NPTH had a positive operating cash flow in 4 of the past 5 years.
NPTH.CA Yearly Net Income VS EBIT VS OCF VS FCFNPTH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

  • NPTH has a Return On Assets (-1.20%) which is comparable to the rest of the industry.
  • NPTH has a Return On Equity of -2.63%. This is comparable to the rest of the industry: NPTH outperforms 53.85% of its industry peers.
  • NPTH's Return On Invested Capital of 5.06% is amongst the best of the industry. NPTH outperforms 84.62% of its industry peers.
Industry RankSector Rank
ROA -1.2%
ROE -2.63%
ROIC 5.06%
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
NPTH.CA Yearly ROA, ROE, ROICNPTH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • Looking at the Operating Margin, with a value of 2.76%, NPTH is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
  • The Gross Margin of NPTH (19.25%) is worse than 69.23% of its industry peers.
  • In the last couple of years the Gross Margin of NPTH has remained more or less at the same level.
Industry RankSector Rank
OM 2.76%
PM (TTM) N/A
GM 19.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
NPTH.CA Yearly Profit, Operating, Gross MarginsNPTH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. NPTH.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NPTH is destroying value.
  • Compared to 1 year ago, NPTH has about the same amount of shares outstanding.
  • The number of shares outstanding for NPTH has been increased compared to 5 years ago.
  • The debt/assets ratio for NPTH has been reduced compared to a year ago.
NPTH.CA Yearly Shares OutstandingNPTH.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
NPTH.CA Yearly Total Debt VS Total AssetsNPTH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • NPTH has an Altman-Z score of 1.83. This is not the best score and indicates that NPTH is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.83, NPTH is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
  • The Debt to FCF ratio of NPTH is 4.69, which is a neutral value as it means it would take NPTH, 4.69 years of fcf income to pay off all of its debts.
  • NPTH has a better Debt to FCF ratio (4.69) than 69.23% of its industry peers.
  • NPTH has a Debt/Equity ratio of 0.56. This is a neutral value indicating NPTH is somewhat dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.56, NPTH belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 4.69
Altman-Z 1.83
ROIC/WACC0.78
WACC6.46%
NPTH.CA Yearly LT Debt VS Equity VS FCFNPTH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 1.12 indicates that NPTH should not have too much problems paying its short term obligations.
  • NPTH's Current ratio of 1.12 is amongst the best of the industry. NPTH outperforms 92.31% of its industry peers.
  • NPTH has a Quick Ratio of 1.12. This is a normal value and indicates that NPTH is financially healthy and should not expect problems in meeting its short term obligations.
  • NPTH's Quick ratio of 1.12 is amongst the best of the industry. NPTH outperforms 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
NPTH.CA Yearly Current Assets VS Current LiabilitesNPTH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. NPTH.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 34.21% over the past year.
  • Looking at the last year, NPTH shows a quite strong growth in Revenue. The Revenue has grown by 18.67% in the last year.
  • The Revenue has been growing slightly by 7.96% on average over the past years.
EPS 1Y (TTM)34.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.97%
Revenue 1Y (TTM)18.67%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%25.79%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.77%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NPTH.CA Yearly Revenue VS EstimatesNPTH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NPTH.CA Yearly EPS VS EstimatesNPTH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 0 0.02 -0.02 0.04 0.06

More info and screens

Find the best growth stocksShow best growing peers

2

4. NPTH.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • NPTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NPTH.CA Price Earnings VS Forward Price EarningsNPTH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NPTH indicates a rather cheap valuation: NPTH is cheaper than 92.31% of the companies listed in the same industry.
  • NPTH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NPTH is cheaper than 84.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.83
EV/EBITDA 7.49
NPTH.CA Per share dataNPTH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NPTH.CA Dividend Analysis

5.1 Amount

  • No dividends for NPTH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NPTH.CA Fundamentals: All Metrics, Ratios and Statistics

NEUPATH HEALTH INC

TSX-V:NPTH (3/9/2026, 7:00:00 PM)

0.45

-0.01 (-2.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-13
Earnings (Next)03-25
Inst Owners10.96%
Inst Owner ChangeN/A
Ins Owners2.56%
Ins Owner ChangeN/A
Market Cap25.34M
Revenue(TTM)83.93M
Net Income(TTM)-553.00K
Analysts80
Price Target0.51 (13.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.78%
Min Revenue beat(2)10.97%
Max Revenue beat(2)20.6%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF 8.83
P/OCF 6.74
P/B 1.21
P/tB N/A
EV/EBITDA 7.49
EPS(TTM)-0.01
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)0.05
FCFY11.33%
OCF(TTM)0.07
OCFY14.83%
SpS1.49
BVpS0.37
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.2%
ROE -2.63%
ROCE 7.03%
ROIC 5.06%
ROICexc 5.89%
ROICexgc 23.5%
OM 2.76%
PM (TTM) N/A
GM 19.25%
FCFM 3.42%
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
F-Score6
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 4.69
Debt/EBITDA 2.53
Cap/Depr 38.3%
Cap/Sales 1.06%
Interest Coverage 7.09
Cash Conversion 81.07%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 1.83
F-Score6
WACC6.46%
ROIC/WACC0.78
Cap/Depr(3y)39.19%
Cap/Depr(5y)26.48%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.97%
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.67%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%25.79%
Revenue Next Year22.77%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y103.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year308.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.94%
FCF growth 3Y3.23%
FCF growth 5YN/A
OCF growth 1Y20.57%
OCF growth 3Y10.75%
OCF growth 5YN/A

NEUPATH HEALTH INC / NPTH.CA FAQ

Can you provide the ChartMill fundamental rating for NEUPATH HEALTH INC?

ChartMill assigns a fundamental rating of 3 / 10 to NPTH.CA.


Can you provide the valuation status for NEUPATH HEALTH INC?

ChartMill assigns a valuation rating of 2 / 10 to NEUPATH HEALTH INC (NPTH.CA). This can be considered as Overvalued.


What is the profitability of NPTH stock?

NEUPATH HEALTH INC (NPTH.CA) has a profitability rating of 3 / 10.


What is the expected EPS growth for NEUPATH HEALTH INC (NPTH.CA) stock?

The Earnings per Share (EPS) of NEUPATH HEALTH INC (NPTH.CA) is expected to grow by 100% in the next year.